Introduction. Cytokeratin-19 (CK19) is recognized as a reliable tumor marker of papillary thyroid carcinoma (PTC). The general prognosis in the classical subtype of PTC (CSTPTC) remains favorable, but some cases can be very aggressive. The aim of this study was to evaluate the localization and intensity of immunohistochemical CK19 expression in CSTPTC and its associations with the clinical and pathological characteristics of patients with CSTPTC in the Silesian region. Material and methods. All the available clinical and histopathological data for 149 patients with CSTPTC from the Silesian region were retrospectively analyzed. The group consisted of 135 (90.6%) women and 14 (9.4%) men (mean age and SD: 52.3 ± 15.0). All these patients with CSTPTC underwent surgery at the same center between 2008 and 2013; the follow-up period was 24 to 90 months (mean and SD: 47 ± 20). Results. In 142 (95.3%) of the patients with CSTPTC, positive cytoplasmic staining of CK19 was found. A higher expression of CK19 was observed in the group of patients without the recurrence of the disease (p = 0.015). CK19 expression was not associated with age, gender, tumor focality, disease stage, tumor size (pT), lymph node involvement (pN), or distant metastases (pM). Conclusions. Decreased CK19 expression in CSTPTC cases with relapse suggests that it plays a role in the carcinoma progression of CSTPTC. The association between lower CK19 expression and patients' unfavorable postoperative course could suggest its possible role as a marker of CSTPTC poor prognosis.
Introduction
Thyroid carcinoma is the most common endocrine malignant tumor, and in recent decades, its incidence has considerably increased [1] [2] [3] . This type of malignancy occurs twice as often in Caucasian people as in Black, but the highest rates occur among patients from Southeast Asia [4] . The incidence of this tumor in Poland is also increasing [5] . It accounts for 2.6% of all oncological diseases in women and 0.5% in men [5] . The majority of thyroid carcinomas arise from follicular cells and, although patients generally have good survival rates and postsurgical prognosis, sometimes these thyroid tumors take a very aggressive course. For this reason, the main goal of recent studies has been to improve the accuracy of the current diagnostic tools so as to identify those tumors with aggressive features [1] [2] [3] . Many clinical and pathological factors are associated with poor prognosis of thyroid carcinoma [6] . The most frequently used are age, gender, distant metastases, lymph node involvement, histopathological subtypes, greater size of primary tumor, and multifocality [6] .
In turn, papillary thyroid carcinoma (PTC) is the most common thyroid malignancy, accounting for 80-90% of all thyroid malignant tumors [7] [8] [9] . As with thyroid carcinomas in general, the prognosis of PTC is favorable, and the ten-year survival rate of the classical subtype of PTC (CSTPTC) is over 90% [9] . CSTPTCs may also be very aggressive, as demonstrated by the recurrence of the disease. Environmental, genetic, immunological, and hormonal factors are considered possible pathomechanisms for thyroid malignancy recurrence [10, 11] .
Besides hematoxylin and eosin staining for evaluating thyroid tumor morphology, immunohistochemical (IHC) methods have been widely used [1, 2] . IHC markers are of two types: those related to proteins present in normal thyrocytes (such as thyroglobulin and thyroid transcription factor-1) and those related to proteins in pathological thyrocytes (such as cytokeratin-19, thyroid peroxidase, and Hector Battifora mesothelial epitope-1) [12] . Cytokeratins (CKs) are a family of intermediate filaments of epithelial cells. In cytoplasm, CK filaments form a specific network connecting the cell membrane with the nucleus, serving to position and anchor the nucleus within the cell. Apart from their mechanical role as components of the cytoskeleton, CKs also participate in cellular processes such as mitosis, the postmitotic period, cell movement, differentiation, and apoptosis [13] .
There are two types of cytokeratins: the acidic cytokeratins and the neutral and basic cytokeratins [14] . Both include specific subsets of cytokeratins, which are numbered from 1 to 20. The acidic type is represented by cytokeratins 9-20, and the neutral and basic type are numbered from 1 to 8 [14] .
The expression of some cytokeratins is often tissue-specific or organ-specific, and these differences also apply to various malignancies [14] . CK profiles have thus been widely determined by immunohistochemistry for the diagnosis and characterization of malignant tumors [15] .
Among the acidic cytokeratins is cytokeratin 19 (CK19), which is composed of approximately 400 amino acids and has a molecular weight of 40 kDa. The human gene encoding CK19 is localized on chromosome 17q21-22 [16, 17] . Some authors have suggested that, during cell differentiation, CK19 can be regarded as a universal cytokeratin, because it can form dimers with any cytokeratin from the second group [18] . Soluble fragments of CK19 can be detected with ELISA using the CYFRA 21-1 assay [19] . CK19 is observed in the ductal epithelium of the pancreas and bile duct, and very often is considered a biomarker of hepatocellular carcinoma, PTC, squamous cell carcinoma, and large bowel adenocarcinoma [20] [21] [22] [23] . Jain et al. [24] pointed to CK19 as an independent prognostic factor for neuroendocrine tumors of the pancreas. High levels of expression of CK19 in thyroid carcinoma have been described not only in humans, but also in animals [25] . Ciaputa et al. described the strong positive immunoreactivity of CK19 in a vesicular-compact type of thyroid carcinoma in dogs [25] .
Positive CK19 staining has been observed in papillary thyroid cancer (PTC), and is recognized as a reliable tumor marker of PTC [12, 26, 27] . In particular, IHC staining of CK19 has been found to be an accurate marker in diagnosing malignancy in thyroid nodules through the immunoreactivity of CK19 in cells obtained during the fine needle aspiration biopsy procedure [28] .
The most common subtypes of PTC include the classic (CSTPTC), follicular, and tall-cell variants [29] . However, many other uncommon variants of PTC have also been described, including oncocytic and columnar cell variants, diffuse sclerosing and solid forms, clear cell and cribriform-morular variant [29] . In 2010, Asioli et al. [30] described another very rare variant of PTC which they called "PTC with prominent hobnail features". However, the usefulness of CK19 as a postsurgical prognostic factor of CSTPTC in various populations is so far unknown or controversial [31, 32] . The aim of our study was thus to investigate relationships between the intensity of CK19 expression at the time of diagnosis of CSTPTC and its clinical and pathological characteristics -and particularly the postsurgical outcomes in patients in the Silesian region of Poland.
Material and methods
The study was approved by the Bioethics Committee of Wroclaw Medical University, Poland (number: KB-419/2015).
Patients.
The study was performed on 149 archival paraffin blocks of 149 histologically diagnosed CSTPTC cases. All patients had been treated surgically at the Department and Clinic of General, Gastroenterological, and Endocrine Sur- www.fhc.viamedica.pl gery at Wroclaw Medical University, Poland. At the time of diagnosis and treatment, the majority of patients were in the very initial stages of the disease (132 patients, 88.59% of the total, in stage I or II); however, there were 15 (10.06%) and 2 (1.34%) patients in stages III and IV, respectively. All individuals underwent the standard total thyroidectomy with central lymphadenectomy. The surgical tissue specimens were fixed in 10% buffered formalin and diagnosed histopathologically at the Department of Pathomorphology, Wroclaw Medical University, Poland. All available clinical and pathological data, along with the postoperative specimens from the 149 patients, were retrospectively examined ( Table 1 ). The group consisted of 135 (90.6%) women and 14 (9.4%) men. The mean age was 52.3 ± 15.0 years. The time of the follow up was 24 to 90 months (mean and SD: 47 ± 20 months). All patients (100%) have survived the follow up period.
Histopathological examination and analysis of IHC. H&E sections were evaluated by two independent pathologists to confirm the diagnosis and to assess whether the CSPTC was unifocal or multifocal. All cases represented classical forms of papillary thyroid carcinoma without any histological variants. The microscopic diagnosis of PTC was based on nuclear features: enlargement, overlapping, irregularity of nuclear contours, grooves, clearing, a ground-glass appearance, nuclear pseudoinclusions, the presence of ovoid cell nuclei, and psammoma bodies. Additionally, papillary carcinomas with classical-type features revealed characteristic papillary architecture, pure or admixed with follicles in variable proportion.
Immunohistochemistry. Archival paraffin tissue blocks were used to obtain 4 μm-thick sections that were transferred onto adhesive slides, deparaffinized in xylene, rehydrated in graded ethanol, and washed in water and phosphate-buffered saline (PBS). Slides were immunostained in an autostainer (Dako, Glostrup, Denmark) with monoclonal antibodies directed against the CK19 antigen (CK19, clone RCK108, Dako). The IHC technique was performed using the EnVision FLEX method (Dako), using the chromogen 5',5'-diaminobenzidine (DAB) as a substrate. Finally, all slides were counterstained with Mayer's hematoxylin (Dako). Appropriate positive and negative controls were prepared. The positive control for CK19 was skin (epidermis). The negative controls were carried out by replacing the primary antibody with PBS. A positive membranous expression with or without cytoplasmic staining of neoplastic cells qualified the case as positive for CK19.
All immunostainings were evaluated by two pathologists using an Olympus BX-41 light microscope (Olympus, Tokyo, Japan), and the immunohistochemical reaction was scored using the so-called Allred score, which is the sum of the percentage score (percentage of immunopositive cells) and the staining intensity score (labeling intensity) [32] . 
Results
The immunoreactivity of CK19 was noted in the cytoplasm and cell membranes of the papillary thyroid carcinoma cells (Figure 1 ). The demographic, clinical, and histopathological characteristics of the patients with CSPTC are presented in Table 1 . One hundred and forty-nine patients -of which 135 (90.6%) were females and 14 (9.4%) males -with a diagnosis of CSPTC were evaluated. The mean age was 52.3 years (± 15.0). The majority of patients had unifocal PTC (141 individuals, 94.6%). Thirteen (8.7%) individuals presented recurrence of PTC in the follow-up period. The majority of patients at the time of diagnosis and treatment were in the earlier stages of the disease (pT1a or pT1b: 115 patients, 77.2%); however, there were 7 (4.7%) and 1 (0.7%) patients in stages pT3 and pT4, respectively. In the case of 24 (16.1%) and 1 (0.7%) individuals, lymph node and distant metastases, respectively, were observed. In 95.3% of examined CSTPTC cases, we observed positive cytoplasmic staining of CK19 ( Table 1) . As shown in Table 2 , the intensity of CK19 immunostaining did not correlate with age (p = 0.570), gender (p = 0.157), tumor focality (p = 0.511), disease stage at the time of diagnosis (p = 0.423), tumor size (pT; p = 0.692), lymph node involvement (pN; p = 0.196), or distant metastases (pM; p = 1.0). However, we found significantly higher expression of CK19 in patients who survived the entire follow-up period without recurrence (p = 0.015, Mann-Whitney test; Figure 2 ). In addition, Figure 3 ). Univariate and multivariate Cox analysis of survival shows Table 3 .
Discussion
It is estimated that about 20% of patients with PTC at the time of diagnosis and treatment had lymph node metastases, and the same number of patients had a more aggressive disease course, with early recurrence of the tumor [33] . Because of this, very accurate markers, which can predict the worse prognosis, even with early treatment, are crucial for clinical management. Some authors have suggested that conventional, histopathological, and immunohistochemical diagnostic methods play an important role in providing a definitive diagnosis and therapeutic guidance [20, 34] . Some biomarkers, such as thyroperoxidase, cytokeratins, galectin-3, and Hector Battifora mesothelial Nearly sixty years ago, Bjorklund proposed CK19 as a possible marker for epithelial tumors [37] ; fifty years later, Uenishi et al. [21] showed that the incidence of extrahepatic disease, such as lymph node metastases, in patients with hepatocellular carcinomas was significantly higher in those with positive expression of CK19. They concluded that positive CK19 expression was a predictor of early postoperative recurrence, due to increased invasiveness. Song et al. [38] clearly established that the immunohistochemical expression of CK19 in PTC allowed nonmalignant thyroid lesions to be distinguished from PTC, which demonstrated diffuse and strong cytoplasmic CK19 staining; however, they did not describe any correlation between CK19 cytoplasmic staining and postoperative course. Very similar results were obtained by Lam et al. [39] . In their study of 153 thyroid carcinoma cases, strong, diffuse staining of CK19 was observed in more than 80% of PTC cases, while focal staining was seen in more than 60% of follicular thyroid carcinomas. In agreement with the previous reports [38, 39] , we observed positive CK19 expression in almost all (95.3%) patients with CSTPTC. In 47 (31.5%), the staining was weak; in 41 (27.5%) medium; and in 54 (36.3%) strong. Only in 7 (4.7%) CSTPTC cases did we see no CK19 expression.
Calangiu et al. [40] provided some new information on the usefulness of CK19 in differentiating the classical and follicular papillary carcinomas and the tall-cell variant of PTC. They observed higher CK19 immunostaining in the classical and follicular types; however, they did not analyze the correlation of CK19 immunostaining with the postsurgical course of the patients. Liu et al. [41] investigated the correlation between CK19 expression and the aggressive behavior of PTC. They showed that the expression of CK19 did not have any association with capsular invasion or lymph node metastases. They also did not consider the postoperative course of their patients in terms of CK19 expression [41] .
In our study, we found the significant correlation of the lower intensity of CK19 expression with a worse prognosis of CSTPTC postsurgical course. In our patients, thus was demonstrated as early recurrence. The higher expression of CK19 was correlated with better postsurgical course -that is, the absence of recurrence. Kosacka et al. [42] presented very similar observations; their study was also performed in the Silesian region, but concerned malignancies of other organs. As in the present study, they showed that higher expression of CK19 in non-small cell lung carcinoma correlated with better prognosis in patients after surgical treatment.
The reasons for the discrepancies in CK19 expression and postsurgical course of PTC are not epitope-1, have some significance in differentiating thyroid carcinomas and have been widely described [20, 35, 36] . However, their value as prognostic factors of the aggressive course of PTC has not been clearly established [2, 20, [34] [35] [36] . Knowledge of high aggressiveness in PTC and the high probability of its early recurrence -even after early primary surgical treatment -may improve the effectiveness of further treatment. clear. Possible explanations include geographical differences; however, a more reasonable explanation could be related to the pathogenic mechanism in thyroid carcinogenesis: the tumor cells express CK19 at the beginning of the malignant process, but perhaps they lose these proteins during the progression of carcinogenetic process.
In our study, the intensity of CK19 expression did not correlate with age, gender, disease stage, primary tumor dimension, multifocality, or lymph node metastases. However, we confirmed the hypothesis that there was a correlation between the intensity of CK19 expression in immunohistochemical staining and the postsurgical course of CSTPTC. Our compositional data analysis offers a novel analytic approach for immunohistochemical studies, providing greater insight into the differences in intensity of staining patterns between papillary thyroid carcinomas. CK19 was expressed by tumor cells in almost all patients with CSPTC in the Silesian region. The higher expression of CK19 Bold -statistically significant values; CI -confidence interval; PTC -papillary thyroid carcinoma. correlated with favorable postoperative course with no recurrence. We suggest that the low expression of CK19 could be a possible indicative factor for recurrence. However, our study also shows great differences between the numbers of patients diagnosed and treated in the initial stages of the disease (132 (88.59%) of patients in stage I or II;) and in the advanced stages, with 15 (10.06%) and 2 (1.34%) individuals, respectively, in stages III and IV. The same situation concerns the recurrence and nonrecurrence subgroups, which contained 136 (91.27%) and 13 (8.72%) patients, respectively. This may affect the statistical analysis. For this reason, our results should be treated as preliminary, and ought to be verified by further studies on larger, more homogenous groups of patients.
